Countries China
On June 30, 2023, the China National Medical Products Administration (NMPA) approved the marketing of Equecabtagene Autoleucel Injection (brand name: FUCAS...
November 22, 2023 | News
Porton Advanced is committed to providing end-to-end gene and cell therapy CDMO services, covering fields such as plasmids, cell therapy, gene therapy, and...
November 21, 2023 | News
WuXi XDC issued a total of 178,446,000 shares under the global offering at an offer price of HK$20.60 per share (being the high-end of the indica...
November 20, 2023 | News
This cutting-edge platform surpasses conventional methods, enabling the screening of thousands of innovative lead molecules against common targets. Sanyou ...
November 20, 2023 | News
As the use of precision oncology therapeutics continues to advance in China, the partnership will provide AmoyDx with access to additional, highly validate...
November 15, 2023 | News
Especially, it has unsurpassed specificity and sensitivity in the detection of membrane receptors such as GPCR receptor-ligand binding affinity test and ex...
November 15, 2023 | News
The group engaged in investment and negotiations with 34 domestic and foreign pharmaceutical enterprises in such areas as the establishment of an industria...
November 13, 2023 | News
Eccogene will receive initial upfront payment of $185 million. Eccogene is also eligible to receive up to $1.825 billion in future clinical,...
November 10, 2023 | News
The goal is to harness the power of large-scale life science models, accelerating the design of AAV vectors, and expanding the application of AI models in ...
November 09, 2023 | News
Gastric cancer is one of the most common gastrointestinal malignancies in the world, and the number of new cases and deaths of gastric cancer in China...
November 08, 2023 | News
LIV-1, also known as SLC39A6 or ZIP6, is a multipass transmembrane protein belonging to the ZIP superfamily of zinc transporters, possesses zinc trans...
November 08, 2023 | News
BioNTech will hold exclusive licenses to develop and commercialize PM8002 globally excluding Greater China Biotheus Inc. ("Biotheus"),...
November 07, 2023 | News
These trials will primarily focus on late-stage solid tumors and the effectiveness will either be evaluated as a standalone therapy or in combination with ...
November 06, 2023 | News
With the help of AI and machine learning models, this collaborative engagement will hopefully lead to the development of more advanced and intelligent solu...
November 06, 2023 | News
Most Read
Bio Jobs
News
Editor Picks